Company intelligence / Profile preview

NanoMedical Systems

Austin, Texas, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Develops implantable drug delivery devices for sustained release of small molecules, peptides, and proteins; in vitro and in vivo studies completed across multiple animal models, with a $3M grant in 2018 for opioid use disorder treatment device.

Modalities: Nanoparticle
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on NanoMedical Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NanoMedical Systems.

Explore the full profile